Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans

References

• Alexander W. S., Roberts A. W., Nicola N. A., Li R., Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoesis in mice lacking the thrombopoietin receptor c-mpl. Blood 1996; 87: 2162–2170
   PubMed Web of Science ®Google Scholar
• Bartley T. D., Bogenberger J., Hunt P., Li Y.-S., Lu H. S., Martin F., Chang M.-S., Samal B., Nichol J. L., Swift S., Johnson M. J., Hsu R.-Y., Parker V. P., Suggs S., Skrine J. D., Merewether L. A., Clogston C., Hsu E., Hokom M. M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M. C. -T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y. P., Lin H., Bosselman R. A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• Bartocci A., Mastrogiannis D. S., Migliorti G., Stockert R. J., Wolkoff A. W., Stanley E. R. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proceedings of the National Academy of Sciences of the United States of America. 1987; 84: 6179–6183
   Google Scholar
• Basser R. L., Clarke K., Rasko J. E.J., Cebon J., Green M. D., Grigg A. P., Zalcberg J., Cohen B., O'Byrne J., Menchaca D., Sheridan W. P., Fox R. M., Begley C. G. Randomised, blinded, placebo-controlled phase 1 trial of pegylatedrecombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 1997; 89: 3118–3128
   PubMed Web of Science ®Google Scholar
• Basser R. L., Rasko J. E.J., Clarke K., Cebon J., Green M. D., Hussein S., Alt C., Menchaca D., Tomita D., Marty J., Fox R. M., Begley C. G. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 1996; 348: 1279–1281
   PubMed Web of Science ®Google Scholar
• Bloedow D., Vadhan-Raj S., Paton V., Johnston T., Yang T., Yang T., Yang T., Senn T., Ashby M., Sims P. Pharmacokinetics of recombinant human thrombopoietin (rhTPO) after intravenous administration in cancer patients (Abstract). Blood 1996; 88: 351a
   Web of Science ®Google Scholar
• Broudy V. C., Lin N. L., Kaushansky K. Thromobopoietin (c-Mpl-ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increase megakaryocyte ploidy, in vitro. Blood 1995; 85: 1719–1726
   PubMed Web of Science ®Google Scholar
• Chang M. S., McNinch J., Basu R., Shutter J., Hsu R., Perkins C., Mar V., Suggs S., Welcher A., Li L., Lu H., BartleyHunt T., Hunt P., Martin F., Samal B., Bogenberger J. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. Journal of Biological Chemistry 1995; 270: 511–514
   PubMed Web of Science ®Google Scholar
• Choi E. S., Nichol J. L., Hokom M. M., Hornkohl A. C., Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402–413
   PubMed Web of Science ®Google Scholar
• de Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W.-J., Oles K. J., Hultgren B., Jr., Colberg L. A., Goeddel D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl-ligand. Nature 1994; 369: 553–538
   Web of Science ®Google Scholar
• Fielder P. J., Gurney A. L., Stefanich E., Marian M., Moore M. W., Carver-Moore K., de Sauvage F. J. Regulation of thrombopoietin levels by c-Mpl-mediated binding to platelets. Blood 1996; 87: 2154–2161
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Kuang W.-J., Xie M.-H., Malloy B. E., Eaton D. L., de Sauvage F. J. Genomic structure, chromosomal localisation, and conserved alternative splice forms of thrombopoietin. Blood 1995; 85: 981–988
   PubMed Web of Science ®Google Scholar
• Harker L. A., Hunt P., Marzec U. M., Kelly A. B., Tomer A., Hanson S. R., Stead R. B. Regulation of platelet production and function by megakaryocyte growth and development factor in non-human primates. Blood 1996; 87: 1833–1844
   PubMed Web of Science ®Google Scholar
• Hokom M. M., Lacey D., Kinder O. B., Choi E., Kaufman S., Faust J., Rowan C., Dwyer E., Nichol J. L., Grasel T., Wilson J., Steinbrink R., Hecht R., Winters D., Boone T., Hunt P. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 1995; 86: 4486–4492
   PubMed Web of Science ®Google Scholar
• Ishikawa M., Okada Y., Satake-Ishikawa R., Kakitana M., Kawagishi M., Matsuki S., Kusada M., Asano K. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by poly ethylene glycol on anticancer drug-induced neutropenia in mice. General Pharmacology 1994; 25: 533–537
   PubMedGoogle Scholar
• Kato T., Iwamatsu A., Shimada Y., Horie K., Kokubo A., Maeda E., Ogami K., Sohma Y., Akahori H., Sudo Y., Kubomura N., Matsumoto A., Tahara T., Ohashi H., Tsumura H., Inoue H., Kawamura K., Miyazaki H. Purification and characterisation of thrombopoietin derived from thromboctyopenic rat plasma. Journal of Biochemistry 1995; 119: 229–236
   Google Scholar
• Kuter D. J., Beeler D. L., Rosenberg R. D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America. 1994; 91: 11104–11108
   Google Scholar
• Kuter D. J., Rosenberg R. D. The reciprocal relationship of thrombopoietin (c-Mpl-ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720–2730
   PubMed Web of Science ®Google Scholar
• Layton J. E., Hockman H., Sheridan W., Morstyn G. Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-regulated control of a regulatory growth factor. Blood 1989; 74: 1303–1307
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Helpel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F.T., Evans S. J., Sheppard P. O., Presnell S. R., O'Hara P. H., Hagen F. S., Roth G. J., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl-ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• McCarthy J. M., Sprugel K. H., Fox N. E., Sabath D. E., Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668–3675
   PubMed Web of Science ®Google Scholar
• Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395–1401
   PubMed Web of Science ®Google Scholar
• Meyers F. J., Paradise C., Scudder S. A., Goodman G., Konrad M. A phase 1 study including pharmacokinetics of polyethylene glycol conjugated interleukin-2. Clinical Pharmacology and Therapeutics 1991; 49: 307–313
   PubMed Web of Science ®Google Scholar
• Nichol J. L., Hokom M. M., Hornkohl A., Sheridan W. P., Ohashi H., Kato T., Li Y. S., Bartley T., Choi E., Bogenberger J., Skrine J. D., Knudten A., Chen J., Trail G., Sleeman L., Cole S., Grampp G., Hunt P. Megakaryocyte growth and development factor: analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. Journal of Clinical Investigation 1995; 95: 2973–2978
   PubMed Web of Science ®Google Scholar
• O'Malley C. J., Rasko J. E.J., Basser R. L., McGrath K. M., Cebon J., Grigg A. P., Hopkins W., Cohen B., O'Byrne J., Green M. D., Fox R. M., Berndt M. C., Begley C. G. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996; 88: 3288–3298
   PubMed Web of Science ®Google Scholar
• Rasko J. E.J., Basser R. L., Boyd J., Mansfield R., O'Malley C. J., Hussein S., Berndt M. C., Clarke K., O'Byrne J., Sheridan W. P., Grigg A. P., Begley C. G. Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. British Journal of Haematology 1997; 97: 871–880
   PubMed Web of Science ®Google Scholar
• Rasko J. E.J., O'Flaherty E., Begley C. G. Mpl-ligand (MGDF) alone and in combination with Stem Cell Factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macro-phage progenitors. Stem Cells 1997; 15: 33–42
   PubMed Web of Science ®Google Scholar
• Roskos L., Stead R., Harker L., Cebon J., Basser R., Begley G., Farese A., McVittie T., Tomita D., Paine T., Cheung E. A cytokinetic model of platelet (PLT) production and destruction following administration of PEG-rHuMGDF (Abstract). Blood 1997; 90: 171a
   Web of Science ®Google Scholar
• Stoffel R., Wiestner A., Skoda R. C. Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567–513
   PubMed Web of Science ®Google Scholar
• Ulich T. R., del Castillo J., Yin S., Swift S., Padilla D., Senaldi G., Bennett L., Shutter J., Bogenberger J., Sun D., Samal B., Shimamoto G., Lee R., Steinbrink R., Boone T., Sheridan W. T., Hunt P. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971–976
   PubMed Web of Science ®Google Scholar
• Yamasaki M., Asano M., Okabe M., Morimoto M., Yokoo Y. Modification of recombinant granulocyte colony-stimulating factor (rhFILGRASTIM) and its derivative ND 28 with polyethylene glycol. Journal of Biochemistry 1994; 115: 814–819
   PubMed Web of Science ®Google Scholar
• Zeigler F. C., de Sauvage G., Widmer H. R., Keller G. A., Donahue C., Schreiber R. D., Malloy B., Hass P., Eaton D., Matthews W. In vitro megakaryo-cytopoietic and thrombopoietic activity of c-Mpl-ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045–4052
   PubMed Web of Science ®Google Scholar